pubmed-article:16304073 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0948089 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
pubmed-article:16304073 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:16304073 | pubmed:issue | 20 | lld:pubmed |
pubmed-article:16304073 | pubmed:dateCreated | 2005-11-23 | lld:pubmed |
pubmed-article:16304073 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:abstractText | The SYNERGY trial comparing enoxaparin and unfractionated heparin in high-risk patients with acute coronary syndromes (ACS) showed that enoxaparin was not inferior to unfractionated heparin in reducing death or nonfatal myocardial infarction (MI) at 30 days. | lld:pubmed |
pubmed-article:16304073 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:language | eng | lld:pubmed |
pubmed-article:16304073 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16304073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16304073 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16304073 | pubmed:month | Nov | lld:pubmed |
pubmed-article:16304073 | pubmed:issn | 1538-3598 | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:WhiteHarvey... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:CaliffRobert... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:CohenMarcM | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:KleimanNeal... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:GoodmanShaun... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:MahaffeyKenne... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:BerdanLisa... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:AylwardPhilip... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:LangerAnatoly... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:FergusonJames... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:ColJacques... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:AntmanElliott... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:SYNERGY... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:ReistCraig... | lld:pubmed |
pubmed-article:16304073 | pubmed:author | pubmed-author:GargJyotsnaJ | lld:pubmed |
pubmed-article:16304073 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16304073 | pubmed:day | 23 | lld:pubmed |
pubmed-article:16304073 | pubmed:volume | 294 | lld:pubmed |
pubmed-article:16304073 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16304073 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16304073 | pubmed:pagination | 2594-600 | lld:pubmed |
pubmed-article:16304073 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:meshHeading | pubmed-meshheading:16304073... | lld:pubmed |
pubmed-article:16304073 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16304073 | pubmed:articleTitle | High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. | lld:pubmed |
pubmed-article:16304073 | pubmed:affiliation | Duke Clinical Research Institute, Durham, NC 27715, USA. mahaf002@mc.duke.edu | lld:pubmed |
pubmed-article:16304073 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16304073 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16304073 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16304073 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16304073 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16304073 | lld:pubmed |